Apr 3, 2026 2:01pm EDT Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 26, 2026 4:01pm EDT Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity